Trial · NCT01027702
Adverse events38
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 38
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Investigations | Infusion of Donor Lymphocytes | 12 | 38 | |
| other | Platelet count decreased | Investigations | Infusion of Donor Lymphocytes | 10 | 38 | |
| other | Leukopenia | Investigations | Infusion of Donor Lymphocytes | 8 | 38 | |
| other | Relapse | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Infusion of Donor Lymphocytes | 6 | 25 | |
| other | Hypoxia | Respiratory, thoracic and mediastinal disorders | Infusion of Donor Lymphocytes | 5 | 38 | |
| other | Rash | Skin and subcutaneous tissue disorders | Infusion of Donor Lymphocytes | 4 | 38 | |
| other | Thrombotic microangiopathy | Blood and lymphatic system disorders | Infusion of Donor Lymphocytes | 3 | 38 | |
| other | Thrombotic microangiopathy | Blood and lymphatic system disorders | Infusion of Donor Lymphocytes | 3 | 38 | |
| other | ALT elevated | Metabolism and nutrition disorders | Infusion of Donor Lymphocytes | 2 | 38 | |
| other | Hemorrage, GU- urinary NOS | Renal and urinary disorders | Infusion of Donor Lymphocytes | 2 | 38 | |
| other | Hypertension | Vascular disorders | Infusion of Donor Lymphocytes | 2 | 38 | |
| other | Hypokalemia | Metabolism and nutrition disorders | Infusion of Donor Lymphocytes | 2 | 38 | |
| other | Pain | General disorders | Infusion of Donor Lymphocytes | 2 | 38 | |
| other | Renal/ Genitorurinary NOS | Renal and urinary disorders | Infusion of Donor Lymphocytes | 2 | 38 | |
| other | Seizures | Nervous system disorders | Infusion of Donor Lymphocytes | 2 | 38 | |
| other | Lymphopenia | Investigations | Infusion of Donor Lymphocytes | 3 | 38 | |
| other | Hypoxia | Respiratory, thoracic and mediastinal disorders | Infusion of Donor Lymphocytes | 3 | 38 | |
| serious | Fever | General disorders | Infusion of Donor Lymphocytes | 24 | 38 | |
| serious | HHV-6 reactivation | Infections and infestations | Infusion of Donor Lymphocytes | 6 | 38 | |
| serious | Graft vs Host disease | Immune system disorders | Infusion of Donor Lymphocytes | 5 | 38 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01027702/events